Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
hypothesis glutathione persister cells

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI - CD8+ T cells

JCI CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione GPX4 Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect JCI Insight Mitochondrial metabolic rewiring sensitizes mTORC1 inhibitor persister cells to cuproptosis hypothesis glutathione persister cells Identification and genetic dissection of convergent cell states Role of Glutathione in Cancer: Vaccinia related kinase 2 inhibition elicits vulnerability of glutathione metabolism in pancreatic cancer Cell Death & Disease

SKU: 79355347312 · From vesmirnicky.sk

4.2
USD27.52 USD59.52

Pay in 4 interest-free payments of $6.88 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

+ Chng oxy ha ca c th v lm chm qu trnh lo ha

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI - CD8+ T cells

Preparation of GSSG standard solution Mix 100 l of 100 mol/l GSSG standard solution and 300 l of 0.5% SSA solution in a microtube to prepare a 25 mol/l GSSG standard solutions

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI - CD8+ T cells

From the sourcing for raw ingredients to quality control labs in our US manufacturing facilities, we maintain one of the most comprehensive safety and quality assurance programs in the industry

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI - CD8+ T cells

USA 108 , 1322413229 (2011)

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI - CD8+ T cells

doi: 10.1016/j.metop.2025.100423

hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition JCI - CD8+ T cells
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products